George Zavoico: Biotech Stocks That Deserve A Closer Look Seeking Alpha Despite several cases of interstitial lung disease in ATTENTION, which led to the trial's discontinuation, we learned that many patients had reconsented and were continuing treatment. We expect top-line results from ATTENTION before year-end. .... The ... |
